Serum immunoglobulin free light chains and post-transplant lymphoproliferative disorder among allogeneic hematopoietic stem cell transplant recipients

Bone Marrow Transplant. 2015 Jan;50(1):146-7. doi: 10.1038/bmt.2014.213. Epub 2014 Sep 29.

Authors

E A Engels¹, O Landgren², R Costello³, D Burton³, S Mailankody³, J Storek⁴

Affiliations

¹ Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
² Myeloma Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
³ Multiple Myeloma Section, National Cancer Institute, Bethesda, MD, USA.
⁴ University of Calgary, Calgary, Alberta, Canada.

No abstract available

Publication types

Clinical Trial
Research Support, N.I.H., Intramural

MeSH terms

Allografts
Hematopoietic Stem Cell Transplantation*
Humans
Immunoglobulin Light Chains / blood*
Lymphoproliferative Disorders / blood*
Lymphoproliferative Disorders / etiology*
Lymphoproliferative Disorders / pathology
Male
Middle Aged

Substances

Immunoglobulin Light Chains

Grants and funding

Z01 CP010150-09/Intramural NIH HHS/United States